Evidence map›Paper›PMID 37123899›Full record

ArticleHeliyon2023

Shatavarin-IV saponin adjuvant elicits IgG and IgG2b responses against

Arivukarasu Palanisamy, Rinku Sharma, Prithvi Pal Singh, Upendra Sharma, Rajendra Damu Patil, Gorakh Mal, Birbal Singh

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Development of semisynthetic saponin immunostimulants.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Arivukarasu PalanisamyDisease Investigation Laboratory, ICAR-Indian Veterinary Research Institute, Regional Station, Palampur 176061, Himachal Pradesh, India.
Rinku SharmaDisease Investigation Laboratory, ICAR-Indian Veterinary Research Institute, Regional Station, Palampur 176061, Himachal Pradesh, India.
Prithvi Pal SinghChemical Technology Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur 176 062, Himachal Pradesh, India.
Upendra SharmaChemical Technology Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur 176 062, Himachal Pradesh, India.
Rajendra Damu PatilDepartment of Veterinary Pathology, DGCN COVAS, CSK HPKV, Palampur 176 062, Himachal Pradesh, India.
Gorakh MalDisease Investigation Laboratory, ICAR-Indian Veterinary Research Institute, Regional Station, Palampur 176061, Himachal Pradesh, India.
Birbal SinghDisease Investigation Laboratory, ICAR-Indian Veterinary Research Institute, Regional Station, Palampur 176061, Himachal Pradesh, India.
Indian Veterinary Research Institute · INInstitute of Himalayan Bioresource Technology · INChaudhary Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Asparagus adscendens fruitImmune responseInactivated S. aureus (Bacterin)Shatavarin-IV adjuvantShatavarin-IV (S-IV) isolation and characterization

Identifiers

PMID37123899
PMCPMC10133762
OpenAlexW4364378053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.